Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
81 Locations available
- Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Conditions: Liver Cancer
1 Location available
- Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
4 Locations available
- Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.
Conditions: Basal Cell Carcinoma - Melanoma - Squamous Cell Carcinoma - Non-Malignant Skin Disorders
1 Location available
- Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Conditions: Head and Neck Cancer
2 Locations available
- Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
Conditions: Brain Cancer - Neoplasm Metastasis - Lung Cancer - Carcinoma, Non-Small-Cell Lung
2 Locations available
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
1 Location available
- Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or
Conditions: Squamous Cell Carcinoma
1 Location available
- Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
Conditions: Squamous Cell Carcinoma - Laryngeal Cancer
1 Location available
- Randomized Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Conditions: Neuroendocrine Tumors - Brain (Nervous System) Cancers - Colon/Rectal Cancer - Colon Cancer - Hepatobiliary Cancers - Hepatocellular Carcinoma (Hepatoma) - Liver
1 Location available
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
Conditions: Upper Aerodigestive Tract Lesions - Neoplasms, Oropharyngeal - Oropharyngeal Cancer - Neoplasms, Hypopharyngeal - Hypopharyngeal Cancer - Head and Neck Neoplasms - UADT Neoplasms - Carcinoma, Squamous Cell - Papilloma
1 Location available
- Humanitarian Device Exemption (HDE) Treatment Protocol
Conditions: Carcinoma, Hepatocellular - Liver Cancer
1 Location available
- Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
8 Locations available
- Radiation With Cetuximab in Head and Neck Squamous Cell Carcinoma Who Do Not Qualify For Chemotherapy
Conditions: Squamous Cell Carcinoma of the Larynx, Hypopharynx, Oropharynx, or Oral Cavity. - The Patients Will be Limited to Age 70 and Older, - OR w/ Co-morbidities Precluding Treatment With Chemotherapy
1 Location available
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Colon Cancer - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Rectal Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurre
1 Location available
- Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Conditions: Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity - Recurrent Squamous Cell
24 Locations available
- Genetic Study of Patients With Inherited Urologic Malignancies
Conditions: Birt Hogg Dube Syndrome - Hereditary Papillary Renal Cell Carcinoma - Kidney Cancer - Multiple Endocrine Neoplasia - Von Hippel-Lindau Syndrome
1 Location available
- Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Recurrent Lymphoepithelioma of the Nasopharynx - Recurrent Squamous Cell Carcinoma of the Nasopharynx - Stage IV Lymphoepithelioma of the Nasopharynx - Stage IV Squamous Cell Carcinoma of the Nasopharynx
1 Location available
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
Conditions: Liver Cancer
3 Locations available
- Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
2 Locations available
- Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Conditions: Esophageal Neoplasms
1 Location available
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark
Conditions: Hepatocellular Carcinoma
1 Location available
- Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma
2 Locations available
- A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancie
Conditions: Renal Cell Carcinoma - Breast Cancer - Colon Cancer - Lung Cancer - Non-Hodgkin Lymphoma
3 Locations available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular - Hepatobiliary Neoplasm - Liver Carcinoma
1 Location available
- Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Conditions: Carcinoma, Hepatocellular
1 Location available
- A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metast
Conditions: Metastatic Colorectal Cancer - Metastatic Gastric Cancer - Metastatic Pancreatic Cancer - Metastatic Hepatocellular Carcinoma - Metastatic Cholangiocarcinoma
1 Location available
- ABT-888 and Temozolomide for Liver Cancer
Conditions: Hepatocellular Carcinoma
1 Location available
- Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)
Conditions: Carcinoma, Renal Cell
1 Location available
- A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma (HCC)
1 Location available
- Phase 1 and 2 Study of PX-866 and Cetuximab
Conditions: Incurable Metastatic Colorectal Carcinoma - Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
31 Locations available
- Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Conditions: HCC
8 Locations available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Conditions: Advanced or Recurrent Solid Tumors - Breast Neoplasms - Ovarian Cancer, Epithelial - Ewing Sarcoma - Small Cell Lung Carcinoma - Prostate Cancer - Pancreas Cancer
5 Locations available
- E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Conditions: Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
7 Locations available
- MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Carcinoma, Small Cell Lung
1 Location available
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma) - Neoplasms
1 Location available
- Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
1 Location available
- RAD001 in Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
3 Locations available
- Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 to Find Oxygen in Tumor Cells of Patients Undergoing Treatment for
Conditions: Cervical Adenocarcinoma - Cervical Squamous Cell Carcinoma - Stage IB Cervical Cancer - Stage IIA Cervical Cancer - Stage IIB Cervical Cancer - Stage III Cervical Cancer - Stage IVA Cervical Cancer - Stage IVB Cervical Cancer
1 Location available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Conditions: Kidney Cancer
2 Locations available
- Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell
1 Location available
- TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Liver Neoplasm - Primary Liver Cancer
1 Location available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- Preoperative Treatment With Cetuximab and/or IMC-A12
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Conditions: Brenner Tumor - Ovarian Carcinosarcoma - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated
17 Locations available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
19 Locations available
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
91 Locations available
- Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx - Stage IV Squamous Cell Carcinoma of the Oropharynx
1 Location available
- Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Conditions: Squamous Cell Carcinoma of Oropharynx
1 Location available
- Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophage
Conditions: Lung Cancer - Esophageal Cancer - Malignant Pleural Mesothelioma - Thymoma - Thymic Carcinoma
1 Location available
- Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Conditions: Liver Cancer
1 Location available
- ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
3 Locations available
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Conditions: Carcinoma, Non-Small-Cell Lung - Head and Neck Neoplasms
4 Locations available
- Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
9 Locations available
- Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
1 Location available
- Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma - Liver Neoplasms - Adenoma, Liver Cell - Carcinoma, Hepatocellular
1 Location available
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma - Osteosarcoma - Astrocytoma - Atypical Teratoid/Rhabdoid Tumor - Ependymoma - Germ Cell Tumor - Glioma - Medulloblastoma - Rhabdoid Tumor - Retinoblastoma - Clear Cell Sarcoma - Renal Cell Carcinoma - Wilms Tumor - Hepatoblastoma - Neurob
1 Location available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
Conditions: Advanced Hepatocellular Carcinoma - HCC - Liver Cancer
1 Location available
- Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
Conditions: Cervical Squamous Cell Carcinoma - Adenosquamous Carcinoma - Adenocarcinoma - Locally Advanced Malignant Neoplasm - Cervical Cancer
1 Location available
- Cardiovascular Effects of Sunitinib Therapy (CREST)
Conditions: Patients With Renal Cell Carcinoma Who Are Newly Initiating Therapy - With the Oral Tyrosine-kinase Inhibitor Sunitinib.
1 Location available
- Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer - Thymoma - Thymic Carcinoma - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Mesothelioma
1 Location available
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Bronchoalveolar Cell Lung Cancer - Large Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer
5 Locations available
- Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Conditions: Squamous Cell Carcinoma of the Head and Neck
2 Locations available
- Association Between Hepatitis C Infection and Renal Cell Carcinoma
Conditions: Hepatitis C - Renal Cell Carcinoma - Colorectal Cancer
1 Location available
- Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
Conditions: Pancreatic Alpha Cell Carcinoma - Pancreatic Beta Islet Cell Carcinoma - Pancreatic Delta Cell Carcinoma - Pancreatic G-cell Carcinoma - Recurrent Islet Cell Carcinoma
3 Locations available
- Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells
Conditions: Squamous Cell Carcinoma
2 Locations available
- AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma - Clear Cell Renal Carcinoma - Clear Cell Renal Cell Carcinoma - Renal Cell Carcinoma
3 Locations available
- Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer
Conditions: Adenocarcinoma of the Lung - Bronchoalveolar Cell Lung Cancer - Non-small Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
1 Location available
- Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI
Conditions: Hepatocellular Carcinoma
1 Location available
- Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Neoplasm Metastases
3 Locations available
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer
1 Location available
- Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
5 Locations available
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Recurrent or Refractory Medulloblastoma - Locally Advanced or Metastatic Basal Cell Carcinoma
2 Locations available
- Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- A Phase I Study of Ridaforolimus and Vorinostat in Patients With Advanced Renal Cell Carcinoma (RCC)
Conditions: Advanced Renal Cell Carcinoma
1 Location available
- Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Conditions: Kidney Cancer
1 Location available
- Study of Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) of the Skin
Conditions: Skin Cancer
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
29 Locations available
- Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Conditions: Acinar Cell Carcinoma of Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Pancreatic Carcinoma Recurrent - Stage IA Pancreatic Cancer - Stage IB Pancreatic Cancer - Stage IIA Pancreatic Cancer - Stage IIB Pancreatic Cancer - Pancreatic Carcinoma Stag
17 Locations available
- ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy
Conditions: Hepatocellular Carcinoma
14 Locations available
- Stereotactic Body Radiotherapy for Liver Tumors
Conditions: Liver Metastases - Hepatocellular Carcinoma - Intrahepatic Cholangiocarcinoma
1 Location available
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer
2 Locations available
- Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Conditions: Head and Neck Cancer
1 Location available
- Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin - Stage I Neuroendocrine Carcinoma of the Skin - Stage II Neuroendocrine Carcinoma of the Skin - Stage III Neuroendocrine Carcinoma of the Skin - Stage IV Neuroendocrine Carcinoma of the Skin
2 Locations available
- BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
Conditions: Metastatic Transitional Cell Carcinoma of the Urothelium
5 Locations available
- The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List
Conditions: Vitamin D Deficiency - Hepatocellular Carcinoma
1 Location available
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer - Oropharyngeal Cancer - Human Papillomavirus - Squamous Cell Cancer
1 Location available
- Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma
1 Location available
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
33 Locations available
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Salivary Gland Squamous Cell Carcinoma - Stage 0 Hypopharyngeal Cancer - Stage 0 Laryngeal Cancer - Stage 0 Lip and Oral Cavity Cancer - Stage 0 Nasopharyngeal Cancer - Stage 0
1 Location available
- Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Adenocarcinoma
1 Location available
- Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC)
Conditions: Renal Cell Carcinoma - Clear-cell Metastatic Renal Cell Carcinoma
10 Locations available
- KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung
2 Locations available
- Trial of Dasatinib in Subjects With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
Conditions: Carcinoma, Non-small Cell Lung
2 Locations available
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Primary Hepatocellular Carcinoma - Chondrosarcoma - Clear Cell Sarcoma of the Kidney -
1 Location available
- Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Conditions: Melanoma - Merkel Cell Carcinoma - Squamous Cell Carcinoma - Penile Carcinoma - Urethral Carcinoma - Extramammary Paget's Disease - Scrotal Carcinoma - Anal Cancer - Vulvar Cancer - Skin Cancer - Lymphadenopathy
1 Location available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic - Small Cell Lung Carcinoma
8 Locations available
- Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
64 Locations available
- Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma of the Oropharynx
2 Locations available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
- Renal Cell Carcinoma (RCC) Scramble
Conditions: Renal Cell Carcinoma
1 Location available
- AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Conditions: Cancer
54 Locations available
- MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
22 Locations available
- The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
Conditions: Hepatocellular Carcinoma
1 Location available
- Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Urinary Bladder Neoplasms
1 Location available
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erloti
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Bronchoalveolar Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer
7 Locations available
- Cabazitaxel - PF Induction Chemotherapy
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma - Endometrial Adenosquamous Cell Carcinoma - Endometrial Clear Cell Carcinoma - Endometrial Papillary Serous Carcinoma - Recurrent Endometrial Carcinoma - Stage III Endometrial Carcinoma - Stage IV Endometrial Carcinoma
1 Location available
- Optical Imaging of Head and Neck Cancer
Conditions: Squamous Cell Carcinoma - Neoplasia - Head and Neck Cancer
1 Location available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
4 Locations available
- Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Conditions: Squamous Cell Carcinoma Of The Head And Neck
1 Location available
- Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
1 Location available
- A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Patients Must Have Histologically or Cytologically Confirmed Non-squamous Cell, Non Small Cell Carcinoma of the Lung. - Patient Must Have Measurable Stage IV Disease (Includes M1a, M1b Stages or Recurrent Disease).
1 Location available
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Olaparib With Cetuximab & Radiation Therapy in Head & Neck Squamous Cell Carcinomas in Patients With Smoking Histories
Conditions: Advanced Cancer of the Head and Neck
1 Location available
- Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
2 Locations available
- Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Recurrent Non-small Cell Lung Cancer - Stage IA Non-small Cell Lung Cancer - Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Ca
1 Location available
- Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Conditions: Childhood Hepatocellular Carcinoma - Papillary Thyroid Cancer - Previously Treated Childhood Rhabdomyosarcoma - Recurrent Childhood Liver Cancer - Recurrent Childhood Rhabdomyosarcoma - Recurrent Thyroid Cancer - Recurrent Wilms Tumor and Other Childhood
69 Locations available
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
Conditions: Unresectable Hepatocellular Carcinoma
8 Locations available
- Temsirolimus as Second-line Therapy in HCC
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma
1 Location available
- Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell of Head and Neck
1 Location available
- Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Viral Therapy in Treating Patient With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Recurrent Adult Primary Liver Cancer
1 Location available
- NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
7 Locations available
- Multiple Ascending Dose
Conditions: Hepatocellular Carcinoma
3 Locations available
- Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Sur
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- Imaging Correlates of Renal Cell Carcinoma Biological Features
Conditions: Renal Cell Carcinoma
1 Location available
- Photodynamic Therapy in Treating Patients With Lung Cancer
Conditions: Adenocarcinoma of the Lung - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage 0 Non-small Cell Lung Cancer
1 Location available
- A Phase 1 Study to Evaluate MEDI4736
Conditions: Advanced Malignant Melanoma - Renal Cell Carcinoma - Non-small Cell Lung Cancer - Colorectal Cancer
4 Locations available
- A Study of the Hedgehog Pathway Inhibitor Vismodegib in Patients With Advanced Solid Malignancies Including Hepatocellular Carcinoma With Varying Degr
Conditions: Solid Cancers
5 Locations available
- Psychosexual Intervention in Patients With Stage I-III Gynecologic Cancer
Conditions: Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Stage I Gestational Trophoblastic Tumor - Stage I Uterine Sarcoma - Stage I Vaginal Cancer - Stage I Vulvar Cancer - Stage IA Cervical Cancer - Stage IA Endometrial Carcinoma - Stage IA Fallop
1 Location available
- Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Conditions: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
1 Location available
- Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer
3 Locations available
- CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck
Conditions: Head and Neck Cancer
13 Locations available
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Non-Small Cell Lung Cancer
6 Locations available
- Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Localized Resectable Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
1 Location available
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Conditions: Ewing Sarcoma - Gastrointestinal Tumor - Germ Cell Tumor - Hepatic Tumor - Lymphoma - Wilms Tumor - Rhabdoid Tumor - Clear Cell Carcinoma - Renal Cell Carcinoma - Melanoma - Neuroblastoma - Rhabdomyosarcoma - Non-rhabdomyosarcoma
1 Location available
- Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Conditions: Carcinoma, Hepatocellular - Intrahepatic Cholangiocarcinoma
1 Location available
- The Quarterback Trial
Conditions: Squamous Cell Carcinomas
1 Location available
- Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer
Conditions: Dysphagia - Pain - Recurrent Squamous Cell Carcinoma of the Oropharynx - Stage I Squamous Cell Carcinoma of the Oropharynx - Stage II Squamous Cell Carcinoma of the Oropharynx - Stage III Squamous Cell Carcinoma of the Oropharynx
1 Location available
- Sorafenib + mFOLFOX for Hepatocellular Carcinoma
Conditions: Hepatocellular Cancer
1 Location available
- Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin - Stage IV Neuroendocrine Carcinoma of the Skin
1 Location available
- Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- A Phase I Study of iPS Cell Generation From Patients With COPD
Conditions: Thoracic Diseases - Respiratory Tract Diseases - Cancer of Lung - Cancer of the Lung - Lung Cancer - Lung Diseases, Obstructive - COPD - Pulmonary Emphysema - Neoplasms, Lung - Neoplasms, Pulmonary - Pulmonary Cancer - Pulmonary Neoplasms - Carcinoma, Non
1 Location available
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions: HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma - HER2 + Breast Cancer - HER2 + Gastric Cancer - Squamous Cell Carcinoma of Head and Neck - Esophageal Squamous Cell Carcinoma
4 Locations available
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendoc
Conditions: Extensive Stage Small Cell Lung Cancer - Large Cell Lung Cancer - Metastatic Carcinoma of Unknown Primary - Neuroendocrine Carcinoma - Newly Diagnosed Carcinoma of Unknown Primary
16 Locations available
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Conditions: Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Pseudomyxoma Peritonei - Recurrent Cervical Cancer - Recurrent Endometrial Carcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor
1 Location available
- A Subject Treatment Preference Study of Tivozanib Hydrochloride Versus Sunitinib in Subjects With Metastatic Renal Cell Carcinoma
Conditions: Metastatic Renal Cell Carcinoma
11 Locations available
- A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
6 Locations available
- Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Conditions: Metastatic Cancers
1 Location available
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, or Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Basal Cell Carcinoma of the Lip - Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity - Rec
1 Location available
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Su
Conditions: Childhood Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
143 Locations available
- Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Conditions: Basal Cell Carcinoma - Squamous Cell Carcinoma
1 Location available
- Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
Conditions: Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurrent Squamous Cell Carcinoma of the Lip and Ora
1 Location available
- Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients With Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage II Pancreatic Cancer - Stage III Pancreatic Cancer
1 Location available
- Imaging Studies of Kidney Cancer Using 18F-VM4-037
Conditions: Carcinoma, Renal Cell - Kidney Neoplasms
1 Location available
- Bevacizumab With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage IV Renal Cell Cancer - Type 1 Papillary Renal Cell Carcinoma - Type 2 Papillary Renal Cell Carcinoma
15 Locations available
- Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Conditions: Breast Neoplasms - Breast Cancer - Adenocarcinomas - Metastatic Solid Tumors Characterized by HER2/Neu Expression
1 Location available
- 6,8-Bis(Benzylthio)Octanoic Acid in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma - Advanced Adult Primary Liver Cancer - Cholangiocarcinoma of the Extrahepatic Bile Duct - Cholangiocarcinoma of the Gallbladder - Localized Unresectable Adult Primary Liver Cancer - Metastatic Extrahepatic Bile D
1 Location available
- Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients
Conditions: Squamous Cell Carcinoma of the Oropharynx - HPV
1 Location available
- Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Conditions: Healthy Volunteers - Lip and Oral Cavity Squamous Cell Carcinoma - Oral Cavity Verrucous Carcinoma - Stage 0 Lip and Oral Cavity Cancer - Tongue Cancer
1 Location available
- Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
Conditions: Infection
1 Location available
- A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Ca
Conditions: Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity - Recurrent Squamous Cell Carcinoma of the Nasopharynx
1 Location available
- Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Conditions: Adenocarcinoma of the Bladder - Recurrent Bladder Cancer - Squamous Cell Carcinoma of the Bladder - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Margin
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma - Head and Neck Cancer
1 Location available
- Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Computed Tomography (CT) Perfusion Imaging of Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
4 Locations available
- Image-Guided Adaptive Conformal Photon Versus Proton Therapy
Conditions: Non-Small-Cell Lung Carcinoma
2 Locations available
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Conditions: Liver Cancer
3 Locations available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer - Squamous Cell Carcinoma, Skin - Carcinoma of the Breast - Malignant Melanoma
5 Locations available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurren
8 Locations available
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Phase 1 Study in Participants With Advanced Cancer
Conditions: Advanced Cancer - Squamous Cell Carcinoma - Carcinoma, Squamous Cell of Head and Neck - Lung Squamous Cell Carcinoma Stage IV - Anal Squamous Cell Carcinoma - Carcinoma, Non-Small-Cell Lung
2 Locations available
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
25 Locations available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
7 Locations available
- Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B - Hepatitis C - Liver Cirrhosis - Hepatocellular Carcinoma - Polycystic Kidney Diseases
1 Location available
- Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
170 Locations available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Advanced Gastric Cancer - Advanced/Metastatic Non-small Cell Lung Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastatic Castration-resistant Prostate Cancer - Metastatic Renal C
1 Location available
- Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer
1 Location available
- SBRT + TACE for Primary Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
4 Locations available
- Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Kidney Cancer
3 Locations available
- Genetic Susceptibility to Kidney Cancer
Conditions: Renal Cell Carcinoma
1 Location available
- LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed
Conditions: Hepatocellular Carcinoma
1 Location available
- Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Conditions: Stage II Lymphoepithelioma of the Nasopharynx - Stage II Squamous Cell Carcinoma of the Nasopharynx - Stage III Lymphoepithelioma of the Nasopharynx - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage IV Lymphoepithelioma of the Nasopharynx - S
1 Location available
- Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma
6 Locations available
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
3 Locations available
- Metastasectomy Study in Renal Cell Carcinoma (RCC)
Conditions: Kidney Cancer
1 Location available
- DNA Chip Based Prognosis of Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
2 Locations available
- A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Conditions: Renal Cell Carcinoma - Metastatic Renal Cell Carcinoma
2 Locations available
- Interleukin 2, Aldesleukin and Entinostat for Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage IV Renal Cell Cancer
5 Locations available
- A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Pri
Conditions: Metastatic Renal Cell Carcinoma
14 Locations available
- Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
Conditions: Liver Cirrhosis - Hepatocellular Carcinoma - Liver Transplantation
1 Location available
- Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Stage I Renal Cell Cancer - Stage II Renal Cell Cancer - Stage III Renal Cell Cancer
3 Locations available
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
43 Locations available
- Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms - Head and Neck Neoplasms - Tongue Neoplasms - Carcinoma, Squamous Cell
2 Locations available
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Conditions: Transitional Cell Carcinoma - Bladder Carcinoma - Urothelial Carcinoma
10 Locations available
- Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma - Kidney Neoplasm - Renal Cancer - Kidney Cancer
1 Location available
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
255 Locations available
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell - Carcinoma, Non-Small-Cell Lung - Lung Cancer
1 Location available
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
1 Location available
- Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses
Conditions: Paranasal Sinus Neoplasms - Squamous Cell Carcinoma
1 Location available
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
Conditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers Liver - Hepatobiliary Cancers
1 Location available
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
Conditions: Hepatocellular Carcinoma
10 Locations available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
12 Locations available
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Bronchoalveolar Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
158 Locations available
- A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Conditions: Cancer Metastatic to the Liver - Recurrent Hepatocellular Carcinoma
1 Location available
- Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Conditions: Superficial Basal Cell Carcinoma
1 Location available
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
376 Locations available
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Patients With Hepa
Conditions: Hepatocellular Carcinoma
20 Locations available
- Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
2 Locations available
- Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Loca
Conditions: Head and Neck Squamous Cell Carcinoma
2 Locations available
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
108 Locations available
- Tesetaxel for Previously Treated Patients With Bladder Cancer
Conditions: Carcinoma, Transitional Cell
2 Locations available
- Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
5 Locations available
- A Study of DS-2248, in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors - Non-small Cell Lung Carcinoma
2 Locations available
- Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer
Conditions: Endometrial Adenocarcinoma - Endometrial Adenosquamous Cell Carcinoma - Endometrial Clear Cell Carcinoma - Endometrial Papillary Serous Carcinoma - Recurrent Endometrial Carcinoma
6 Locations available
- Stereotactic Body Radiotherapy for Head and Neck Tumors
Conditions: Squamous Cell Carcinoma of the Head and Neck - Nasopharyngeal Carcinoma - Salivary Gland Cancer - Head and Neck Sarcoma - Paraganglioma of Head and Neck - Chordoma of Head and Neck - Chondrosarcoma of Head and Neck - Angiofibroma of Head and Neck
1 Location available
- Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Ce
1 Location available
- Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Nasopharynx - Stage IV Squamous Cell Carcinoma of the Nasopharynx
4 Locations available
- Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and
Conditions: Advanced Renal Cell Carcinoma - Gastrointestinal Stromal Tumors - Pancreatic Neuroendocrine Tumors
3 Locations available
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Conditions: Recurrent Bladder Cancer - Stage III Bladder Cancer - Stage IV Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Conditions: Hepatocellular Carcinoma
15 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Conditions: Hemangioblastoma - Hereditary Neoplastic Syndrome - Hippel Lindau Disease - Neoplasm - Renal Cell Carcinoma
1 Location available
- Veliparib, Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or F
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial
12 Locations available
- A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Conditions: Liver Cancer
10 Locations available
- Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell Ca
Conditions: Histological Evidence of Metastatic Clear Cell Renal Cell Carcinoma - That Has Been Previously Treated With 1-3 Prior Regimens. Phase 1 Only, Any Number of Prior Regimens - With Evidence of Progressive Disease on or Within 6 Months - of Discontinuing Suni
1 Location available
|